Table 2:
Sources of Incidentally Identified VUS Reporting |
---|
Referring physician requests expanded variant list |
Interpretation of variant pathogenicity evolves over time |
Discrepancies in interpretation between genetic testing companies/laboratories |
VUS identified on gene panel sent for incorrect clinical indication |
Non-CLIA-approved genetic testing, direct to consumer/consumer-initiated panels |
Research-based genetic testing |